Feline calicivirus VP1-based mRNA vaccine protects cats against FCV challenge

Authors:

Abstract
• An FCV-VP1 mRNA-LNP vaccine was constructed, utilizing a safe, flexible non-viral platform. • The vaccine elicits effective, durable neutralizing antibodies, protecting cats from FCV challenge. • This mRNA vaccine provided complete protection in cats, offering a novel effective strategy against FCV infection.
Funding Information
  • Key Research and Development Program of Heilongjiang

This publication has 11 references indexed in Scilit: